• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·IAM
Share

Iambic Therapeutics Stocks

¤ 0Last Updated 15.10.2026

Issuer Rating

Performance

Risk

Recommendation

Sell

¤ 0
Key Takeaways

Risk factor

Profitability factor

Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

15.10.2026 15:00

Iambic IPO: Trading Begins in the Biotech Stock, Backed by Nvidia and Cathie Wood

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.10.2026 15:26

Morning in New York: AI Leaders Lose Ground, and Inflation Adds Fuel to the Fire

15.10.2026 15:13

SpaceX may announce a merger with Tesla no later than early December — Barclays

15.10.2026 15:00

Iambic IPO: Trading Begins in the Biotech Stock, Backed by Nvidia and Cathie Wood

15.10.2026 14:25

Nvidia, AMD, and Micron fell in U.S. pre-market trading. The sell-off in AI stocks continues

15.10.2026 13:52

Smartphone shipments plummeted 22% last quarter—the worst decline on record

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026